Market Overview:
The global sevelamer market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic kidney diseases (CKDs) and rising awareness about the benefits of sevelamer therapy. Sevelamer is used for the treatment of hyperphosphatemia and secondary hyperparathyroidism in patients with CKD. It helps reduce serum phosphorus levels by binding phosphate in the gastrointestinal tract, which prevents its absorption into the bloodstream. The global sevelamer market is segmented on the basis of type, application, and region. On the basis of type, it is divided into tablet and oral suspension. Tablet dominates this market owing to its ease-of-use and convenience over oral suspension formulations. By application, it is classified into adult and pediatric segments. Adult segment dominates this market due to high incidence rates of CKD across all regions globally as compared to pediatric population. Geographically, it covers North America, Latin America, Europe Asia Pacific & Middle East & Africa (MEA). North America leads this market due to early adoption rates for novel therapies among patients suffering from CKD.
Product Definition:
Sevelamer is a medication used to treat high levels of phosphorus in the blood caused by certain types of kidney disease. It works by binding to phosphorus in the food you eat, preventing it from being absorbed into your blood.
Tablet:
Tablet is a form of digital media that can be used for various purposes such as education, entertainment, gaming and communication. The most commonly used tablets are the ones with a 10 inch display size. They are lightweight and easy to carry devices that have high-resolution displays which make them suitable for viewing HD content. Tablets also provide better viewing experience due to their larger display size as compared to smartphones and other smart devices with smaller screen sizes.
Oral Suspension:
Oral suspension is a drug delivery system that involves the active ingredient to be suspended in a carrier fluid. The most commonly used oral suspending agents are alcohols, glycerol, and oils. Other types of carriers include milk and water. Oral suspension is widely used for the treatment of dental caries as it allows easy application of medication on teeth surfaces by simply pouring the liquid onto them.
Application Insights:
The global sevelamer market is segmented by application into adult and pediatric patients. The adult population was estimated to be around 1,000 million in 2016 and is expected to reach over 1,200 million by 2030. Growth in the geriatric population coupled with rising awareness regarding cholesterol reduction is anticipated to drive the demand for oral sevelamer suspension in adults during the forecast period.
The pediatric population consists of children aged 6 years and above.
Regional Analysis:
North America dominated the global sevelamer market in 2017. The presence of a large number of manufacturers and suppliers coupled with high healthcare expenditure, awareness about kidney diseases, and adoption of advanced therapies for the treatment of kidney diseases are some factors attributing to its largest share. In addition, increasing R&D activities by various organizations is contributing towards market growth. For instance, International Renal Association (IRF) has undertaken several initiatives such as Kidney Disease Outcomes Survey (KDOS) to understand the burden of kidney disease in different regions globally.
Asia Pacific region is expected to witness lucrative growth over the forecast period owing to rising disposable income leading to improved health care access which subsequently leads increased incidence rates of chronic disorders such as diabetes.
Growth Factors:
- Increasing prevalence of chronic kidney diseases (CKD) and rising geriatric population: The global prevalence of CKD is estimated to be around 10%. The number of people with CKD is projected to increase from 26 million in 2010 to 38 million by 2030. This will create a large pool of patients for whom sevelamer therapy will be required, thereby driving the growth of the sevelamer market. Additionally, the geriatric population (aged 65 years or above) is growing at a rapid pace and accounted for 12% of the global population in 2015. This segment is expected to grow significantly in coming years, thus propelling demand for sevelamer products.
- Growing awareness about benefits offered by sevelamer: There has been an increasing awareness among healthcare professionals and patients about the benefits offered by sevelamer products over other therapies for managing CKD symptoms such as hyperphosphatemia and proteinuria. This has led to an increase in its adoption across regions worldwide.
- Availability of generic versions: A number of generic manufacturers have entered into the market since patent protection on Renagel/Renalvia expired in 2009-2010, resulting in a decline in their prices over time (~60%). This has made these products more affordable and accessible to a larger patient population, thereby driving their uptake globally..
Scope Of The Report
Report Attributes
Report Details
Report Title
Sevelamer Market Research Report
By Type
Tablet, Oral Suspension
By Application
Adult, Pediatric
By Companies
Sanofi, Impax Laboratories, InvaGen Pharmaceuticals, Dr. Reddy's Laboratories, Aurobindo Pharma, Amneal Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global Sevelamer Market Report Segments:
The global Sevelamer market is segmented on the basis of:
Types
Tablet, Oral Suspension
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Pediatric
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Impax Laboratories
- InvaGen Pharmaceuticals
- Dr. Reddy's Laboratories
- Aurobindo Pharma
- Amneal Pharmaceuticals
Highlights of The Sevelamer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Oral Suspension
- By Application:
- Adult
- Pediatric
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sevelamer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sevelamer is a medication used to treat heart failure. It works by helping the body to produce more blood.
Some of the key players operating in the sevelamer market are Sanofi, Impax Laboratories, InvaGen Pharmaceuticals, Dr. Reddy's Laboratories, Aurobindo Pharma, Amneal Pharmaceuticals.
The sevelamer market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sevelamer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sevelamer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sevelamer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sevelamer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sevelamer Market Size & Forecast, 2018-2028
4.5.1 Sevelamer Market Size and Y-o-Y Growth
4.5.2 Sevelamer Market Absolute $ Opportunity
Chapter 5 Global Sevelamer Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Sevelamer Market Size Forecast by Type
5.2.1 Tablet
5.2.2 Oral Suspension
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Sevelamer Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Sevelamer Market Size Forecast by Applications
6.2.1 Adult
6.2.2 Pediatric
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sevelamer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sevelamer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Sevelamer Analysis and Forecast
9.1 Introduction
9.2 North America Sevelamer Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Sevelamer Market Size Forecast by Type
9.6.1 Tablet
9.6.2 Oral Suspension
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Sevelamer Market Size Forecast by Applications
9.10.1 Adult
9.10.2 Pediatric
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Sevelamer Analysis and Forecast
10.1 Introduction
10.2 Europe Sevelamer Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Sevelamer Market Size Forecast by Type
10.6.1 Tablet
10.6.2 Oral Suspension
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Sevelamer Market Size Forecast by Applications
10.10.1 Adult
10.10.2 Pediatric
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Sevelamer Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Sevelamer Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Sevelamer Market Size Forecast by Type
11.6.1 Tablet
11.6.2 Oral Suspension
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Sevelamer Market Size Forecast by Applications
11.10.1 Adult
11.10.2 Pediatric
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Sevelamer Analysis and Forecast
12.1 Introduction
12.2 Latin America Sevelamer Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Sevelamer Market Size Forecast by Type
12.6.1 Tablet
12.6.2 Oral Suspension
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Sevelamer Market Size Forecast by Applications
12.10.1 Adult
12.10.2 Pediatric
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Sevelamer Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Sevelamer Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Sevelamer Market Size Forecast by Type
13.6.1 Tablet
13.6.2 Oral Suspension
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Sevelamer Market Size Forecast by Applications
13.10.1 Adult
13.10.2 Pediatric
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sevelamer Market: Competitive Dashboard
14.2 Global Sevelamer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Impax Laboratories
14.3.3 InvaGen Pharmaceuticals
14.3.4 Dr. Reddy's Laboratories
14.3.5 Aurobindo Pharma
14.3.6 Amneal Pharmaceuticals
